RISK OF BLEEDING IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH ATEZOLIZUMAB/BEVACIZUMAB: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Kim, Young Seok [1 ]
机构：
[1] Soon Chun Hyang Univ, Asan, South Korea
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1794
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Risk of Bleeding in Hepatocellular Carcinoma Patients Treated with Atezolizumab/Bevacizumab: A Systematic Review and Meta-Analysis
    Song, Young-Gi
    Yeom, Kyeong-Min
    Jung, Eun Ae
    Kim, Sang Gyune
    Kim, Young Seok
    Yoo, Jeong-Ju
    LIVER CANCER, 2024, 13 (06) : 590 - 600
  • [2] Incidence and Risk of Hypertension in Cancer Patients Treated With Atezolizumab and Bevacizumab: A Systematic Review and Meta-Analysis
    Jiang, Linhan
    Tan, Xiaoxia
    Li, Jun
    Li, Yaling
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Atezolizumab Plus Bevacizumab Versus Lenvatinib for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Lu, Jinpeng
    Lin, Xinyi
    Teng, Haiwen
    Zheng, Yansong
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (06): : 643 - 651
  • [4] Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis
    Kulkarni, Anand V.
    Tevethia, Harshvardhan
    Kumar, Karan
    Premkumar, Madhumita
    Muttaiah, Mark D.
    Hiraoka, Atsushi
    Hatanaka, Takeshi
    Tada, Toshifumi
    Kumada, Takashi
    Kakizaki, Satoru
    Vogel, Arndt
    Finn, Richard S.
    Rao, Padaki Nagaraja
    Pillai, Anjana
    Reddy, Duvvur Nageshwar
    Singal, Amit G.
    ECLINICALMEDICINE, 2023, 63
  • [5] SAFETY AND EFFICACY OF ATEZOLIZUMAB/ BEVACIZUMAB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND IMPAIRED LIVER FUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Pasta, Andrea
    Calabrese, Francesco
    Jaffe, Ariel
    Labanca, Sara
    Marenco, Simona
    Pieri, Giulia
    Torres, Maria Corina Plaz
    Strazzabosco, Mario
    Giannini, Edoardo G.
    LIVER CANCER, 2024, 13 (03) : 235 - 245
  • [6] Systematic review and meta-analysis of safety and efficacy of atezolizumab/ bevacizumab in Child-Pugh class B patients with hepatocellular carcinoma
    Pasta, A.
    Calabrese, F.
    Jaffe, A.
    Labanca, S.
    Marenco, S.
    Pieri, G.
    Torres, M. C. Plaz
    Strazzabosco, M.
    Giannini, E. G.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S221 - S221
  • [7] Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis
    Vogel, Arndt
    Finn, Richard S.
    Zumofen, Marie-Helene Blanchet
    Heuser, Carolina
    Alvarez, Javier Sanchez
    Leibfried, Michael
    Mitchell, Catherine R.
    Batson, Sarah
    Redhead, Gabrielle
    Gaillard, Vincent E.
    Kudo, Masatoshi
    LIVER CANCER, 2023, 12 (06) : 510 - 520
  • [8] Efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
    Junning Liu
    Linfeng Yang
    Song Wei
    Jijiang Li
    Pengsheng Yi
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 16191 - 16201
  • [9] Efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
    Liu, Junning
    Yang, Linfeng
    Wei, Song
    Li, Jijiang
    Yi, Pengsheng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (17) : 16191 - 16201
  • [10] Risk of Variceal Bleeding in Patients With Advanced Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab
    Ha, Yeonjung
    Kim, Jee Hyun
    Cheon, Jaekyung
    Jeon, Gyeong Sik
    Kim, Chan
    Chon, Hong Jae
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (09) : 2421 - +
12345